课题基金 / 基金详情

Ontogeny and functional characterization of splenic fibroblastic reticular cells (FRCs) and their mesenchymal precursors during homeostasis, immune-activation and infection

Ontogeny and functional characterization of splenic fibroblastic reticular cells (FRCs) and their mesenchymal precursors during homeostasis, immune-activation and infection
脾成纤维网状细胞(FRC)及其间充质前体细胞在稳态、免疫激活和感染过程中的个体发育和功能特征
批准号:
270343329
负责人:
Professor Dr. Thomas Hehlgans
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2019-12-31

项目摘要

项目成果

Professor Dr. Thomas Hehlgans的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Secondary lymphatic organs (SLOs) such as the spleen provide specialized microenvironmental niches for the development and control of immune responses. Particular mesenchymal stromal cells known as fibroblastic reticular cells (FRCs) generate distinct compartments that permit, for example, highly efficient interaction of T cells with dendritic cells. Importantly, FRCs are more than simple scaffold-building cells; these cells actively participate in inducing and shaping innate and adaptive immune responses. Our own preliminary data demonstrate that the structure and function of the splenic white pulp exclusively depends on lymphotoxin-beta-receptor (LTbR) signaling received by CCL19 positive FRCs during adult life and/or their putative progenitors, i.e. mesenchymal lymphoid tissue organizer cells (mLTOs). In continuation of our existing collaborative activities, we have developed a novel inducible lineage tracing model that permits genetic tagging of splenic FRCs and their progenitors in vivo and will thus facilitate the elucidation of their differentiation pathways throughout spleen development. In addition, this model system provides means for the identification and characterization of molecular mechanisms involved in the maintenance of splenic structure and immune-competence during adult life. Thus, in combination with our already established experimental model of cell type-specific loss of LTbR function, we will be able to resolve the temporal requirement of LTbR signaling for differentiation and function of adult splenic FRCs and their putative progenitors in the embryo. Finally, using an experimental model that facilitates cell type specific re-activation of LTbR expression in a timely controlled manner, we will test the hypothesis whether FRC-restricted LTbR expression within a specific time window is sufficient for proper white pulp formation and function during embryonic life. Furthermore, we will elucidate the requirements for a timely controlled LTbR activation during adult life in order to maintain compartmentalization and function of the splenic white pulp. Our proposed objectives are based on our individual expertise and present the continuation of our successful collaborative activities. More specifically, they are designed to molecularly characterize splenic FRCs and to dissect lineage relationship of splenic FRCs with other splenic stromal cells, e.g. their differentiation from mLTO precursors during embryonic development. Moreover, we will be able to identify and functionally characterize the cellular and molecular mechanisms through which LTbR expressing FRCs are involved in the maintenance of lymphoid organ integrity and immune-competence in the adult spleen, i.e. their ecological role in the splenic micro-environment during immune homeostasis, activation and infection.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41467-019-09728-3
发表时间: 2019-04-15
期刊: NATURE COMMUNICATIONS
影响因子: 16.6
作者: [Cheng, Hung-Wei, Onder, Lucas, Ludewig, Burkhard]
通讯作者: Ludewig, Burkhard
DOI: 10.1016/j.immuni.2017.05.008
发表时间: 2017-07-18
期刊: IMMUNITY
影响因子: 32.4
作者: [Onder, Lucas, Moerbe, Urs, Ludewig, Burkhard]
通讯作者: Ludewig, Burkhard
Functional Characterization of beta-defensins in Inflammation
  • 批准号:
    175696419
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2010
  • 负责人:
    Professor Dr. Thomas Hehlgans
  • 依托单位:
The role of beta-defensins in allogeneic transplantation
  • 批准号:
    181826348
  • 项目类别:
    Clinical Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2010
  • 负责人:
    Professor Dr. Thomas Hehlgans
  • 依托单位:
Functional Characterization of Lymphotoxin-beta-Rezeptor Activation in Inflammation
  • 批准号:
    45060842
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2007
  • 负责人:
    Professor Dr. Thomas Hehlgans
  • 依托单位:
Die Rolle des Lymphotoxin beta-Rezeptors bei entzündlichen Darmerkrankungen
  • 批准号:
    15849136
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2005
  • 负责人:
    Professor Dr. Thomas Hehlgans
  • 依托单位:
国内基金
海外基金
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
  • 批准号:
    82371873
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    乔洁
  • 依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    沃雁
  • 依托单位: